Skip to main content
NHTC logo

NHTC · Natural Health Trends Corp

Track NHTC — free
$0.97 -0.03 (-2.92%)
Market Cap
$7.73M
Shares
8.58M
Volume · Oct 7 5924 Avg daily vol (3M) 56.18K

Price & Indicators

Drag to pan · scroll to zoom
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$1.00 Open$0.98 Day$0.97–1.03 52W close$0.90–4.62 Avg vol 30d75K Short int32K · 0.4% float · 1.0d Short vol4% Last earningsJul 29, 2026 DataJan 2020–Oct 2026 Filing10-Q · Jul 29

Up next

Next earnings call
Oct 28, 2026 Est · unconfirmed · in 3 wks
filed Jul 29, 2026
call held Jul 29, 2026

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
$38.24M
Trailing 12 months
Net income (TTM)
−$1.16M
Trailing 12 months
Revenue growth YoY
-14.3%
Year over year
Operating margin
-5.1%
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
-96.4%
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
$21.23M
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
-11.7%
Year over year · fewer shares
Price change (1Y)
-78.1%
Trailing year
Short interest
0.4%
Latest settlement · 1.0 days to cover
View all 115 metrics

AI Brief

Q2 FY26 earnings call · Jul 29, 2026
Q2 FY26

TL;DR. NHTC reported a 23% decline in Q2 revenue to $7.6 million and a net loss of $451,000, driven by weak China consumer demand, regulatory uncertainty, and member conduct violations, while restructuring delivered margin and opex savings and the board resumed buybacks with $15.9 million remaining.

Bullish
  • + Restructuring lifted gross margin to 75.2% and cut operating expenses by ~$300,000 in Q2, with YTD savings above $600,000 and more expected in H2.
  • + Board authorized resumption of share repurchases with $15.9 million remaining, signaling confidence in the business.
  • + Launched new Super Nutri-1 greens powder with encouraging early customer response across markets.
  • + Operating cash use improved to $2.2 million used in H1 2026 vs. $5.2 million used in H1 2025.
Bearish
  • − Q2 revenue fell 23% to $7.6 million from $9.8 million, with H1 revenue down 18% to $16.8 million.
  • − Operating loss widened to $643,000 from $333,000, and net loss of $451,000 ($0.05/share) versus $15,000 net income a year ago.
  • − Member conduct violations in Hong Kong disrupted the business and hurt Q2 revenue and operating results.
  • − Cash and securities fell to $18.6 million from $28.9 million at year-end 2025 due to buybacks and dividends.

AI-generated from the earnings call and 8-K · may contain errors · not investment advice

Equibles Rating

blended score · not investment advice
Overall
Strong Sell
SellHoldBuy
Technical Strong Sell Momentum Very Weak Sentiment Neutral Fundamentals Weak Quant / Vol Very High
Market backdrop VIX 15 · calm Equity put/call 0.57
Technical
price trend
Strong Sell
50 / 200-day cross No cross
Price vs 200-day avg −60%
below
Price vs 50-day avg −34%
below
RSI (14) 30
oversold
MACD trend Negative
52-week position 3%
near low
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Very Weak
1-month return −39%
trailing
6-month return −64%
trailing
YTD return −68%
this year
Relative strength −75%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $2 › 200d $3 — 200d above 50d
Institutional flow Distributing
-4% holders QoQ · +2 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
0.37% of float · ▼ -20.9% MoM · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
23 holders — mid 3-yr range
Squeeze score 22
low risk · 0–100
Fundamentals
Weak
Revenue growth −7%
Y/Y
Gross margin 74%
contracting
EPS growth −260%
Y/Y
Free cash flow $-6.1M
Buyback $15.9M
remaining
Quant / Vol
risk profile
Very High
Volatility 80%
annualized · 1-yr
Max drawdown −81%
past year
ATR 10.6%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

Latest guidance · from the 8-K filed Nov 5, 2025
by mid-2026
Annualized savings from restructuring initiatives $1.5M
fourth quarter
One-time charge related to restructuring initiatives $250,000
first quarter next year
Quarterly cash dividend per share $0.10

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Strong Sell
4 · 3 · 0
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−60% Bearish
Price vs 50-day avg
−34% Bearish
RSI (14)
30 Neutral
MACD trend
Negative Bearish
52-week position
3% Bearish
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
Mixed
Trend (MA cross) No cross
50d $2 › 200d $3 — 200d above 50d
Institutional flow Distributing
-4% holders QoQ · +2 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
0.37% of float · ▼ -20.9% MoM · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
23 holders — mid 3-yr range
Price context
position in its 52-week range
Range low $1 Now $1 · 3% Range high $5
vs 200-day avg -60% vs 50-day avg -34%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

Earlier KPI extraction records exist, but do not meet the current evidence-completeness requirements. No current verified series is available. Earlier figures remain withheld until revalidated; this is not evidence that the company reports no KPIs.

Versus peers

Internet Retail — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
NHTC
Natural Health Trends Corp
this stock
$7.73M -67.6% -7.4% — 0.4%
AMZN
Amazon Com Inc
$2.66T +11.0% +12.4% 19.8 0.8%
BABA
Alibaba Group Holding Ltd
$267.88B -25.5% +8.1% — 1.7%
PDD
PDD Holdings Inc.
$110.41B -30.9% +14.5% — 2.0%
MELI
Mercadolibre Inc
$88.85B -7.8% +39.1% 47.7 1.6%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Reducing
Holders
23
% held
12.1%
Net QoQ
-50.2K sh
Top holder
RENAISSANCE TECHNOLOGIES…
Held Float
View
Held by Funds
Fund positions
11
View
Short & Settlement
Short Interest Falling
Shares short
32.0K
Days to cover
1.0d
Change
-8.5K sh
View
Short Volume
Short vol %
4%
As of
Oct 6, 2026
Short Total
View
Fails to Deliver
FTD shares
66
Value
$105
As of
Sep 11, 2026
View
Off-Exchange
Off-exchange %
54.7%
Week of
Aug 31, 2026
Off-exch Lit
View
Financials
Financials
Revenue (FY)
$39.8M
Net income (FY)
$-882.0K
EPS diluted
$-0.08
View
Buybacks
Remaining
$15.9M
View
Filings
SEC Filings
Latest
8-K
Filed
Jul 29, 2026
This year
10
View
Exempt Offerings
Offering
$42.6K
Filed
Feb 14, 2023
View
Earnings & Events
Webcasts
Last webcast
Jul 29, 2026
View

Performance

5D 20D 120D MTD YTD
NHTC -2.9% -38.7% -64.2% -2.9% -67.6%
SPY +2.0% +1.7% +11.3% +2.2% +14.3%
vs SPY -4.9% -40.4% -75.5% -5.1% -81.9%

Capital returns

Buyback program · as of Jun 30, 2026
Authorized
—
Spent (derived)
—
Remaining
$15.90M

Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

Key facts CIK 912061 CUSIP 63888P406 13F (30d) 1 filings 1 filers Visit website Investor relations